Latest News of CIEN
A Nobel Prize-winning scientist who wrote a book on aging cycles 6 miles a day at age 72. Here are 3 things he does to stay healthy.
By Business Insider |
5 hours ago
Nobel laureate Venki Ramakrishnan discusses the surge in aging research and caution against unproven anti-aging treatments. He emphasizes the significance of lifestyle choices like diet, exercise, and...
Maravai LifeSciences (MRVI) Q3 2024 Earnings Call Transcript
By Yahoo! Finance |
5 hours ago
Maravai LifeSciences reported Q3 2024 revenues of $65 million, slightly below expectations. The Biologics Safety Testing segment was impacted by a soft bioprocessing market, while the Nucleic Acid Pro...
Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ...
By Yahoo! Finance |
6 hours ago
In Q4, the firm expects to fulfill $14 million of commitments. Factors influencing NAP revenue decline are project delays to 2025 and a weaker market. The acquisition for 2025 brings low single-digit ...
-
Lumen Technologies, Inc. (NYSE:LUMN) Taps Google Cloud AI, Enhances Network Efficiency with Lumen® Digital Twin
By Yahoo! Finance | 14 hours agoAI is transforming industries rapidly, with tech giants investing billions in AI-related expenditures. The US government under Trump is expected to focus on strengthening AI. Startups like Physical In...
-
RXO, with Coyote in the fold, projects big jump in efficiency-driven savings
By Yahoo! Finance | 16 hours agoRXO's third-quarter earnings were impacted by the recent acquisition of Coyote Logistics, leading to a significant change in projections. Despite a stock decline, management remains optimistic about t...
-
Global Medical Tech Becton, Dickinson Expects Lower China Sales, Bioscience And Pharma Market Dynamics To Impact 2025 Organic Revenue Growth
By Yahoo! Finance | 19 hours agoBecton, Dickinson and Company reported strong fourth-quarter sales, exceeding expectations. The company is focusing on higher-growth areas and innovation to enhance patient care. BD projects growth an...
-
Arcus Biosciences Inc (RCUS) Q3 2024 Earnings Call Highlights: Strong Cash Position and ...
By Yahoo! Finance | 1 day agoTerry Rosen, CEO, discussed the direct move to human studies without preclinical work with Fallu and CA. Atrumid program's next steps are being planned post ARC nine data. The strategy for IO-naive re...
-
Quote of the Day: There Is Joy in This Mudville: Scientists Solve 'Magical' Muck
By The New York Times | 1 day agoDouglas Jerolmack from the University of Pennsylvania discusses how mud used on baseballs can inspire sustainable materials for various industries due to its unique properties of spreading like face c...
-
Gilead Sciences (GILD) Q3 2024 Earnings Call Transcript
By Yahoo! Finance | 1 day agoGilead Sciences reported strong third quarter results with growth across HIV, oncology, and liver disease segments....
-
Gilead Sciences Post Higher 3Q Revenue, Raises FY Guidance
By MarketWatch | 1 day agoGilead Sciences reported strong Q3 results, with higher revenue and raised full-year outlook. Net income of $1.25 billion, beating analysts' forecasts. Revenue rose 7% to $7.55 billion, driven by incr...
-
Ancient gameshows, long-dead stars, Gregg Wallace ... I'm fascinated by Mum's taste in TV | Adrian Chiles
By The Guardian | 1 day agoThe writer shares an experience with their mum's strict TV viewing schedule, opting for traditional broadcasts over streaming services. The nostalgia of old shows brings melancholy reflections and mom...
-
Cytek Biosciences Inc (CTKB) Q3 2024 Earnings Call Highlights: Revenue Growth and Positive Net ...
By Yahoo! Finance | 2 days agoThe CEO discusses the normalized demand environment in the US, emphasizing the essential role of flow cytometry in biology labs. The CFO expects sequential revenue growth in Q4 and outlines strategies...
-
Exact Sciences Corp (EXAS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
By Yahoo! Finance | 2 days agoCFO Aaron Bloomer explained the sequential decline in Q4 guidance due to hurricane impacts and care program shifts. For 2025, growth is expected from re-screens, care programs, Cologuard Plus launch, ...
-
Exact Sciences (EXAS) Q3 2024 Earnings Call Transcript
By Yahoo! Finance | 2 days agoExact Sciences reported advancements in the third quarter, including test result delivery to 1.2 million patients, revenue growth, and improved EBITDA and cash flow....
-
Integra Lifesciences Holdings Corp (IART) Q3 2024 Earnings Call Highlights: Navigating ...
By Yahoo! Finance | 3 days agoExpect mid-single-digit organic growth in 2025 despite quality holds in Q4. No significant hurricane impacts on procedures or IV shortages. $10 million impact from shipping holds in Q4. Gross margin h...